iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/28260367/
[The pharmacogenomics of CFH Y402H and wet age-related macular degeneration] - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 11;53(2):144-147.
doi: 10.3760/cma.j.issn.0412-4081.2017.02.014.

[The pharmacogenomics of CFH Y402H and wet age-related macular degeneration]

[Article in Chinese]
L L Chen  1 , Y Y Chen
Affiliations
Review

[The pharmacogenomics of CFH Y402H and wet age-related macular degeneration]

[Article in Chinese]
L L Chen et al. Zhonghua Yan Ke Za Zhi. .

Abstract
in English, Chinese

Age-related macular degeneration(AMD) is one of the main leading causes of irreversible vision damage in patients over 50 years old. Genetic factors play an important role in the occurrence and development of AMD. Since the significant correlation between complement factor H (CFH) gene and AMD was found, the pharmacogenomics of CFH polymorphism was paid close attention by academic circles. Among which, studies concerning CFH Y402H were more deeply. Studies have found CFH Y402H genotypes might lead to differences toward the outcome of PDT and anti-VEGF treatment. In this article, we review the researches on the pharmacogenomics of CFH Y402H in wet AMD treatment. (Chin J Ophthalmol, 2017, 53: 144-147).

AMD是50岁以上人群发生视力不可逆性损伤的主要原因之一。遗传因素在AMD的发生、发展中起到了重要的作用。自发现补体因子H（CFH）基因与AMD的发生具有显著相关性后，学界开始关注CFH基因多态性对AMD治疗的影响，其中关于CFH Y402H基因的研究较为深入。多项研究发现CFH Y402H不同基因型对光动力治疗及抗VEGF治疗效果存在差异。现就CHF Y402H基因在湿性AMD药物遗传学方面的研究进展进行综述。（中华眼科杂志，2017，53：144-147）.

Keywords: Complement factor H; Macular degeneration; Pharmacogenetics.

PubMed Disclaimer

Similar articles

See all similar articles

Substances

LinkOut - more resources